Semaglutide or Tirzepatide: GLP-1 receptor agonists work through entirely different mechanisms (appetite suppression, glucose regulation, delayed gastric emptying) compared to AOD-9604s direct lipolytic effects
Reference: Dimet-Wiley AL, Latham CM, Brightwell CR, Neelakantan H, Keeble AR, Thomas NT, Noehren H, Fry CS, Watowich SJ (2024)
Barbi C
B12 does not suppress appetite or block fat storage
In randomized controlled trials in people living with HIV and central fat accumulation, tesamorelin produced clinically meaningful reductions in visceral adipose tissue in a majority of patients and was associated with improvements in liver enzymes when deep abdominal fat decreased
Additionally, BPC-157 may protect the gastrointestinal tract, aid in ulcer healing, and support overall gut health